Document
IPR2016-01332, No. 1020 Exhibit - Harris 2002 (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1020 Exhibit - Harris 2002 (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 2081-88 Exhibit - JSN 2081 Genentech March 12, 2010 Press Release (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2081-88 Exhibit - JSN 2081 Genentech March 12, 2010 Press Release (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2135-130 Exhibit - JSN 2135 Truven Commercial and Medicare Data (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2135-130 Exhibit - JSN 2135 Truven Commercial and Medicare Data (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1082-9 Exhibit - Hofmann Declaration (P.T.A.B. Feb. 8, 2017)
Cite Document
IPR2016-01332, No. 1082-9 Exhibit - Hofmann Declaration (P.T.A.B. Feb. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1010 Exhibit - Jan 11, 2103 (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1010 Exhibit - Jan 11, 2103 (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 2006-13 Exhibit - JSN 2006 Hoffman Deposition Ex 1 JJ 2015 4th Q results (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2006-13 Exhibit - JSN 2006 Hoffman Deposition Ex 1 JJ 2015 4th Q results (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2061-68 Exhibit - JSN 2061 Body, ¿¿¿Low dose prednisone and increased risk of development of bone metastases,¿¿¿ Annals of Oncology, 7643 645 1996 (P.T.A.B. Mar. 8, 2...
Cite Document
IPR2016-01332, No. 2061-68 Exhibit - JSN 2061 Body, ¿¿¿Low dose prednisone and increased risk of development of bone metastases,¿¿¿ Annals of Oncology, 7643 645 1996 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2042-50 Exhibit - JSN 2042 Papatsoris et al, ¿¿¿Novel Biological Agents for the Treatment of Hormone Refractory Prostate Cancer HRPC,¿¿¿ (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2042-50 Exhibit - JSN 2042 Papatsoris et al, ¿¿¿Novel Biological Agents for the Treatment of Hormone Refractory Prostate Cancer HRPC,¿¿¿ (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2028-34 Exhibit - JSN 2028 Declaration of Professor Ian Judson, MD (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2028-34 Exhibit - JSN 2028 Declaration of Professor Ian Judson, MD (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1115-181 Exhibit - Labrie 1989 (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1115-181 Exhibit - Labrie 1989 (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2082-89 Exhibit - JSN 2082 Mulcahy, Medscape October 17, 2008 Press Release (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2082-89 Exhibit - JSN 2082 Mulcahy, Medscape October 17, 2008 Press Release (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2011-39 Exhibit - JSN 2011 Part 2 Garnick Deposition Ex 3 ¿¿¿ Blackhard, Letter to Editor, J Urology, 14661621 1622 1991 (P.T.A.B. Mar. 8, 2017)
Cite Document
IPR2016-01332, No. 2011-39 Exhibit - JSN 2011 Part 2 Garnick Deposition Ex 3 ¿¿¿ Blackhard, Letter to Editor, J Urology, 14661621 1622 1991 (P.T.A.B. Mar. 8, 2017)
+ More Snippets
Document
IPR2016-01332, No. 1036 Exhibit - Initial Application (P.T.A.B. Jun. 30, 2016)
Cite Document
IPR2016-01332, No. 1036 Exhibit - Initial Application (P.T.A.B. Jun. 30, 2016)
+ More Snippets
Document
IPR2016-01332, No. 1111-177 Exhibit - Goodman 2001 (P.T.A.B. Apr. 19, 2017)
Cite Document
IPR2016-01332, No. 1111-177 Exhibit - Goodman 2001 (P.T.A.B. Apr. 19, 2017)
+ More Snippets
Document
IPR2016-01332, No. 2020-26 Exhibit - JSN 2020 Williams et al, ¿¿¿Objective Responses to Ketoconazole Therapy inPatients with Relapsed Progressive Prostatic Cancer,¿¿¿ (P.T.A.B. Mar. 8, 2017...
Cite Document
IPR2016-01332, No. 2020-26 Exhibit - JSN 2020 Williams et al, ¿¿¿Objective Responses to Ketoconazole Therapy inPatients with Relapsed Progressive Prostatic Cancer,¿¿¿ (P.T.A.B. Mar. 8, 2017)
+ More Snippets